Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911 - Langer,C.J.; Harris,J.; Horwitz,E.M. (J Clin Oncol, 2007)